Zinzani, P. L. Et Al. 2022. Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib. 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Louisiana, United States Of America), 6470-6473.

Zinzani, P. L., ÖZCAN, M., Capra, M., Santoro, A., Panayiotidis, P., Bouabdallah, K., ... Jurczak, W.(2022). Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib . 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) (pp.6470-6473). Louisiana, United States Of America

Zinzani, Pier Et Al. "Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib," 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 2022

Zinzani, Pier L. Et Al. "Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.6470-6473, 2022

Zinzani, P. L. Et Al. (2022) . "Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.6470-6473.

@conferencepaper{conferencepaper, author={Pier Luigi Zinzani Et Al. }, title={Pooled Safety Analysis from Phase I-III Studies for Patients with Hematological Malignancies Treated with the PI3K Inhibitor Copanlisib}, congress name={64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Louisiana}, country={United States Of America}, year={2022}, pages={6470-6473} }